Clinical Trial Update: FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing FOLFOXIRI versus FOLFOX as first-line therapy for metastatic colorectal cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLFOX
• FOLFOXIRI (folinic acid (leucovorin), fluorouracil (5-FU), oxaliplatin, irinotecan)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN